GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Definitive Healthcare Corp (NAS:DH) » Definitions » Sloan Ratio %

Definitive Healthcare (Definitive Healthcare) Sloan Ratio % : -12.17% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Definitive Healthcare Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Definitive Healthcare's Sloan Ratio for the quarter that ended in Mar. 2024 was -12.17%.

As of Mar. 2024, Definitive Healthcare has a Sloan Ratio of -12.17%, indicating there is a warning stage of accrual build up.


Definitive Healthcare Sloan Ratio % Historical Data

The historical data trend for Definitive Healthcare's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Definitive Healthcare Sloan Ratio % Chart

Definitive Healthcare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
- -2.98 -1.44 9.71 -11.60

Definitive Healthcare Quarterly Data
Jul19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.21 2.70 -3.32 -11.60 -12.17

Competitive Comparison of Definitive Healthcare's Sloan Ratio %

For the Health Information Services subindustry, Definitive Healthcare's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Definitive Healthcare's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Definitive Healthcare's Sloan Ratio % falls into.



Definitive Healthcare Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Definitive Healthcare's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-202.388-41.19
--31.782)/1825.901
=-11.60%

Definitive Healthcare's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(-199.843-42.822
--22.346)/1810.145
=-12.17%

Definitive Healthcare's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was -8.566 (Jun. 2023 ) + -171.526 (Sep. 2023 ) + -10.233 (Dec. 2023 ) + -9.518 (Mar. 2024 ) = $-199.8 Mil.
Definitive Healthcare's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 12.037 (Jun. 2023 ) + 9.487 (Sep. 2023 ) + 4.709 (Dec. 2023 ) + 16.589 (Mar. 2024 ) = $42.8 Mil.
Definitive Healthcare's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was 1.34 (Jun. 2023 ) + -54.059 (Sep. 2023 ) + 54.407 (Dec. 2023 ) + -24.034 (Mar. 2024 ) = $-22.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Definitive Healthcare  (NAS:DH) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Definitive Healthcare has a Sloan Ratio of -12.17%, indicating there is a warning stage of accrual build up.


Definitive Healthcare Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Definitive Healthcare's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Definitive Healthcare (Definitive Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
492 Old Connecticut Path, Suite 401, Framingham, MA, USA, 01701
Definitive Healthcare Corp is a leading provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of its revenue from the United States.
Executives
Carrie Lazorchak officer: Chief Revenue Officer C/O DEFINITIVE HEALTHCARE CORP., 492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM MA 01701
Scott G Stephenson director C/O VERISK ANALYTICS, INC., 545 WASHINGTON BOULEVARD, JERSEY CITY NJ 07310-1686
Sea Vii Management, Llc director, 10 percent owner ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent International Gp, Llc director, 10 percent owner 800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199
Spectrum Vii Investment Managers' Fund, L.p. director, 10 percent owner ONE INTERNATIONAL PLACE, 35TH FLOOR, BOSTON MA 02110
Jason Ronald Krantz director, 10 percent owner, officer: Chief Executive Officer C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Jonathan Maack officer: President C/O DEFINITIVE HEALTHCARE CORP., 550 COCHITUATE RD, FRAMINGHAM MA 01701
Sastry Chilukuri director 5 BUDDY LANE, MORRISTOWN NJ 07960
David Randall Winn director 7900 GLADES ROAD, SUITE 540, BOCA RATON FL 33434
Jeffrey Charles Haywood director, 10 percent owner C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Richard Douglas Booth officer: Chief Financial Officer 200 CLARENDON STREET, T-9, BOSTON MA 02116
Kathleen A Winters director 101 COLUMBIA ROAD, MORRISTOWN NJ 07960
Spectrum Vii Co-investment Fund, L.p. director, 10 percent owner ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent Global Technology-c Limited Partnership director, 10 percent owner PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069
Advent Global Technology-d Limited Partnership director, 10 percent owner PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069